The CDISC Glossary version 7.0 defines terms commonly used in clinical research (including acronyms, abbreviations, and initials). The Glossary serves the community of clinical researchers by selecting and defining terms pertaining to clinical research, particularly eClinical investigations, sponsored by the pharmaceutical industry or a federal agency. Note this CDISC Glossary is NOT comprehensive for all words bearing on human health, medicine, or laboratory methods.
The Glossary includes references and links to other glossaries such as regulatory dictionaries and to health-related controlled terminologies known to be useful in conducting clinical research, including the CDISC Terminology Project. Glossary terms are organized alphabetically, by first word, according to the opinion of the Glossary Project Team concerning most common usage in clinical research. Thus “source document verification” would appear under “source,” not “verification.” The Glossary follows the practice of preceding certain terms with the letter “e” to denote that they pertain to electronic or Web implementation.
Standardized Definitions for Cardiovascular and Stroke End Point Events in Clinical Trials
This document includes the draft standardized definitions for cardiovascular and stroke end point events in clinical trials that were developed as a result of the Standardized Data Collection for Cardiovascular Clinical Trials Initiative. These definitions are referenced in the CDISC Therapeutic Area User Guide-Cardiovascular v1.0 (TAUG-CV) which will be released later in 2014.